Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

High Risk Cytogenetic Abnormalities Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients Received Autologous Hematopoietic Cell Transplantation

Blood (2024) 144 (Supplement 1): 6925.

https://doi.org/10.1182/blood-2024-205155

Published: 2024

Journal Articles

Preliminary Safety and Efficacy Results of EDI001: An Investigator Initiated Trial on CRISPR/Cas9-Modified Autologous CD34 + Hematopoietic Stem and Progenitor Cells for Patients with Transfusion Dependent β-Thalassemia

Blood (2022) 140 (Supplement 1): 10652–10653.

https://doi.org/10.1182/blood-2022-166365

Published: 2022

Journal Articles

Pharmacokinetics-Guided Perioperative Replacement Therapy in Hemophilia a Patients

Lei Meng, Jiaxin Lv, Bin Chen, Qiang Li, Zhuqin Liu, Guiyong Jiang, Yufang Xun, Fei Liu, Keyu Chen, Qifa Liu, Jing Sun

Blood (2021) 138 (Supplement 1): 2108.

https://doi.org/10.1182/blood-2021-149551

Published: 2021

Journal Articles

Coagulation Dysfunction and Hematological Changes in 633 Patients with COVID-19

Mo Yang, Huixia Deng, Liuming Yang, Liang Li, PhD, Jieyu Ye, PhD, Yucai Cheng, Yafang Tan, Beng H Chong, MBBS, PhD, Qiang Li

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-140274

Published: 2020

Journal Articles

Comparison of Short-Term Tertiary Prophylaxis at Low-Dose and Intermediate-Dose for Adults with Severe Hemophilia a in China

Shunhua Huang, Zhitao Li, Yang Liu, Fangmei Qin, Xiaoqin Feng, MDPhD, Qiang Li, Xuan Zhou, MD, Jing Sun, MD

Blood (2015) 126 (23): 4681.

https://doi.org/10.1182/blood.V126.23.4681.4681

Published: 2015

Journal Articles

Comparison of Short-Term Tertiary Prophylaxis at Low-Dose and Intermediate-Dose for Adults with Severe Hemophilia a in China

Shunhua Huang, Zhitao Li, Yang Liu, Fangmei Qin, Xiaoqin Feng, MDPhD, Qiang Li, Xuan Zhou, MD, Jing Sun, MD

Blood (2015) 126 (23): 4675.

https://doi.org/10.1182/blood.V126.23.4675.4675

Published: 2015

Journal Articles

Identification of BCL6 As a Therapeutic Target in RAS -Driven Acute Lymphoblastic Leukemia

Qiang Li, PhD, Christian Hurtz, PhD, Seyedmehdi Shojaee, PhD, Zhengshan Chen, MDPhD, Huimin Geng, PhD, Gang Xiao, PhD, Mignon L. Loh, MD, B. Hilda Ye, PhD, Ari Melnick, MD, Markus Muschen, MDPhD

Blood (2015) 126 (23): 556.

https://doi.org/10.1182/blood.V126.23.556.556

Published: 2015

Journal Articles

PU.1 Is Essential For MLL Leukemia Via Activation Of The Meis/HOX Pathway and A Monocytic Cytokine Mediated Anti-Apoptotic Inflammatory Program

Blood (2013) 122 (21): 1276.

https://doi.org/10.1182/blood.V122.21.1276.1276

Published: 2013

Journal Articles

Cited2 Is Required For The Maintenance Of Glycolytic Metabolism In Adult Hematopoietic Stem Cells

Jinwei Du, PhD, Qiang Li, PhD, Fangqiang Tang, PhD, Michelle Puchowitz, PhD, Hasashi Fujioka, PhD, Sally Dunwoodie, PhD, David Danielpour, PhD, Yu-Chung Yang, PhD

Blood (2013) 122 (21): 794.

https://doi.org/10.1182/blood.V122.21.794.794

Published: 2013

Journal Articles

Identification of a calmodulin-binding domain in Sema4D that regulates its exodomain shedding in platelets

Peipei Mou, Zhao Zeng, Qiang Li, Xiaohui Liu, Xiaoran Xin, Kenneth M. Wannemacher, Changgeng Ruan, Renhao Li, Lawrence F. Brass, Li Zhu

Blood (2013) 121 (20): 4221–4230.

https://doi.org/10.1182/blood-2012-11-470609

Published: 2013

Journal Articles

HIF-1 α deletion partially rescues defects of hematopoietic stem cell quiescence caused by Cited2 deficiency

Jinwei Du, Yu Chen, Qiang Li, Xiangzi Han, Cindy Cheng, Zhengqi Wang, David Danielpour, Sally L. Dunwoodie, Kevin D. Bunting, Yu-Chung Yang

Blood (2012) 119 (12): 2789–2798.

https://doi.org/10.1182/blood-2011-10-387902

Published: 2012

Includes: Supplemental data

Journal Articles

Identification of a Region within the Cytoplasmic Domain of Sema4D That Binds Calmodulin and Regulates Shedding of the Sema4D Exodomain in Platelets,

Peipei Mou, BS, Zhao Zeng, BS, Lijie Ren, MS, Qiang Li, BS, Kenneth M Wannemacher, PhD, Xi Mo, PhD, Lawrence F. Brass, MD, PhD, Li Zhu, MD, PhD

Blood (2011) 118 (21): 3249.

https://doi.org/10.1182/blood.V118.21.3249.3249

Published: 2011

Journal Articles

Essential Role for PU.1 in MEIS1 Activation and MLL Fusion Leukemia,

Jing Zhou, Bo Li, Jun Wu, Fuhong He, Qiang Li, Xiaomei Yan, Yue Zhang, Lixia Zhang, Xinghui Zhao, Jin Yan, Marcelo Nobrega, Daniel G. Tenen, Gang Huang, Qian-fei Wang

Blood (2011) 118 (21): 3466.

https://doi.org/10.1182/blood.V118.21.3466.3466

Published: 2011

Journal Articles

A Humanin Analog Attenuates Platelet Responses to Vascular Injury

Lijie Ren, MS, Qiang Li, BS, Zhao Zeng, BS, Peipei Mou, BS, Xiaohui Liu, MS, Xiaorong Tang, BS, Qiongyu Lu, MS, Xingshun Xu, MD, PhD, Li Zhu, MD, PhD

Blood (2011) 118 (21): 1131.

https://doi.org/10.1182/blood.V118.21.1131.1131

Published: 2011

Journal Articles

Cited2 Regulates Hematopoietic Stem Cell Quiescence Through HIF-1α Dependent and Independent Pathways

Jinwei Du, Yu Chen, Qiang Li, Zhengqi Wang, Sally Dunwoodie, Kevin D. Bunting, PhD, Yu-Chung Yang, PhD

Blood (2011) 118 (21): 912.

https://doi.org/10.1182/blood.V118.21.912.912

Published: 2011

Journal Articles

Global reduction of the epigenetic H3K79 methylation mark and increased chromosomal instability in CALM-AF10–positive leukemias

Yi-Hui Lin, Purvi M. Kakadia, Ying Chen, Ya-Qiang Li, Aniruddha J. Deshpande, Christian Buske, Kang-Ling Zhang, Yi Zhang, Guo-Liang Xu, Stefan K. Bohlander

Blood (2009) 114 (3): 651–658.

https://doi.org/10.1182/blood-2009-03-209395

Published: 2009

Includes: Supplemental data

NARROW

High Risk Cytogenetic Abnormalities Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients Received Autologous Hematopoietic Cell Transplantation

Preliminary Safety and Efficacy Results of EDI001: An Investigator Initiated Trial on CRISPR/Cas9-Modified Autologous CD34 + Hematopoietic Stem and Progenitor Cells for Patients with Transfusion Dependent β-Thalassemia

Pharmacokinetics-Guided Perioperative Replacement Therapy in Hemophilia a Patients

Coagulation Dysfunction and Hematological Changes in 633 Patients with COVID-19

Comparison of Short-Term Tertiary Prophylaxis at Low-Dose and Intermediate-Dose for Adults with Severe Hemophilia a in China

Comparison of Short-Term Tertiary Prophylaxis at Low-Dose and Intermediate-Dose for Adults with Severe Hemophilia a in China

Identification of BCL6 As a Therapeutic Target in RAS -Driven Acute Lymphoblastic Leukemia

PU.1 Is Essential For MLL Leukemia Via Activation Of The Meis/HOX Pathway and A Monocytic Cytokine Mediated Anti-Apoptotic Inflammatory Program

Cited2 Is Required For The Maintenance Of Glycolytic Metabolism In Adult Hematopoietic Stem Cells

Identification of a calmodulin-binding domain in Sema4D that regulates its exodomain shedding in platelets

HIF-1 α deletion partially rescues defects of hematopoietic stem cell quiescence caused by Cited2 deficiency

Identification of a Region within the Cytoplasmic Domain of Sema4D That Binds Calmodulin and Regulates Shedding of the Sema4D Exodomain in Platelets,

Essential Role for PU.1 in MEIS1 Activation and MLL Fusion Leukemia,

A Humanin Analog Attenuates Platelet Responses to Vascular Injury

Cited2 Regulates Hematopoietic Stem Cell Quiescence Through HIF-1α Dependent and Independent Pathways

Global reduction of the epigenetic H3K79 methylation mark and increased chromosomal instability in CALM-AF10–positive leukemias

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only